首页 > 最新文献

Journal of minimally invasive surgery最新文献

英文 中文
Robotic single-port plus one assist port splenectomy in an adult: a case report with video. 机器人单端口加一个辅助端口脾切除术一例成人:附视频的病例报告。
Pub Date : 2025-12-15 DOI: 10.7602/jmis.2025.28.4.209
Su Hyung Park, Sung Hyun Kim, Chang Moo Kang

Minimally invasive techniques are increasingly used in hepatobiliary and pancreatic surgeries, but robotic single-port (SP) splenectomy remains uncommon due to the rarity of splenic diseases. We present a case of a 57-year-old woman with left upper quadrant pain and a 4.3-cm splenic mass suggestive of hamartoma. Due to persistent symptoms and cosmetic concerns, robotic SP splenectomy was performed using the da Vinci SP system (Intuitive Surgical, Inc.) via a transumbilical incision, with an additional assist port in the left abdomen. The procedure lasted 264 minutes with minimal blood loss, and the patient was discharged without complications on postoperative day 9. Histopathology confirmed a splenic hamartoma. This case highlights the feasibility and safety of robotic SP splenectomy in adults, suggesting potential for wider application with further experience and refinement.

微创技术越来越多地应用于肝胆胰手术,但由于脾脏疾病的罕见性,机器人单孔脾切除术仍然不常见。我们报告一位57岁的女性,因左上腹疼痛和4.3厘米脾肿块提示错构瘤。由于持续的症状和美容方面的考虑,使用达芬奇SP系统(Intuitive Surgical, Inc.)通过经脐切口进行机器人SP脾切除术,在左腹部有一个额外的辅助口。手术持续264分钟,出血量最小,患者于术后第9天无并发症出院。组织病理学证实为脾错构瘤。该病例强调了机器人SP脾切除术在成人中的可行性和安全性,表明随着进一步的经验和改进,有可能得到更广泛的应用。
{"title":"Robotic single-port plus one assist port splenectomy in an adult: a case report with video.","authors":"Su Hyung Park, Sung Hyun Kim, Chang Moo Kang","doi":"10.7602/jmis.2025.28.4.209","DOIUrl":"10.7602/jmis.2025.28.4.209","url":null,"abstract":"<p><p>Minimally invasive techniques are increasingly used in hepatobiliary and pancreatic surgeries, but robotic single-port (SP) splenectomy remains uncommon due to the rarity of splenic diseases. We present a case of a 57-year-old woman with left upper quadrant pain and a 4.3-cm splenic mass suggestive of hamartoma. Due to persistent symptoms and cosmetic concerns, robotic SP splenectomy was performed using the da Vinci SP system (Intuitive Surgical, Inc.) via a transumbilical incision, with an additional assist port in the left abdomen. The procedure lasted 264 minutes with minimal blood loss, and the patient was discharged without complications on postoperative day 9. Histopathology confirmed a splenic hamartoma. This case highlights the feasibility and safety of robotic SP splenectomy in adults, suggesting potential for wider application with further experience and refinement.</p>","PeriodicalId":73832,"journal":{"name":"Journal of minimally invasive surgery","volume":"28 4","pages":"209-212"},"PeriodicalIF":0.0,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12715284/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145764683","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current status of treatment for esophagojejunostomy leakage after total gastrectomy in patients with gastric cancer: a multicenter retrospective study in Korea. 韩国胃癌全胃切除术后食管空肠造口瘘治疗现状:一项多中心回顾性研究
Pub Date : 2025-12-15 DOI: 10.7602/jmis.2025.28.4.184
Min-Chan Kim, Mi Ran Jung, Jeong Ju Noh, Sunghwa Kang, Jae Hun Chung, Ji-Ho Park, Tae-Han Kim, Jae Kyun Park, Yoonhong Kim, Sang Hyuk Seo, Sung Eun Kim, Oh Kyung Kwon, Ji Yeon Park, Ki Bum Park, Sun-Hwi Hwang, Si-Hak Lee, Young-Joon Lee, Sang-Ho Jeong, Tae-Yong Jeon, Dae Hwan Kim, Chang In Choi, Ki Young Yoon, Kyung Won Seo, Ki Hyun Kim, Sang Hoon Oh, Kwang Hee Kim

Purpose: Esophagojejunostomy leakage (EJL) remains one of the most critical complications following total gastrectomy for gastric cancer. This study aimed to evaluate the evolving therapeutic approaches and clinical outcomes of EJL using data from a large-scale multicenter retrospective cohort.

Methods: Among 6,577 patients who underwent total gastrectomy or proximal gastrectomy with double tract reconstruction at nine institutions from 2003 to 2024, 196 (3.0%) developed EJL. Of these, 162 patients with comprehensive clinical data were included in the final analysis. The study examined treatment modalities, changes in management over time, patient characteristics, surgical variables, and clinical outcomes. Four groups were defined according to treatment approach: conservative, endoscopic, reoperation, and multimodal (combined) therapy.

Results: Endoscopic therapy was first introduced in 2011 and has progressively supplanted reoperation, now comprising 32.5% of cases. The average time to EJL diagnosis was 8.4 days after surgery. Overall in-hospital mortality was 6.1% (10/162). When conservative management was excluded, endoscopic treatment demonstrated the highest rate of therapeutic success (94.3%, p = 0.004). Both the duration until diet resumption and length of hospital stay were notably reduced in the endoscopic and conservative groups compared with reoperation and multimodal therapy (p < 0.001). Moreover, although the highest post-leakage hospitalization costs were observed with multimodal treatment (p < 0.001), overall hospitalization expenses were significantly lower for patients managed conservatively or with endoscopic intervention (p < 0.001).

Conclusion: Over the past two decades, management of EJL has shifted toward endoscopic approaches. Endoscopic therapies yield superior clinical outcomes and should be considered a primary option for appropriate candidates.

目的:食管空肠造口漏是胃癌全胃切除术后最严重的并发症之一。本研究旨在利用大型多中心回顾性队列数据,评估EJL的治疗方法和临床结果。方法:2003 - 2024年9所医院6577例全胃或近端胃切除术合并双胃道重建患者中,196例(3.0%)发生EJL。其中162例临床资料全面的患者纳入最终分析。该研究考察了治疗方式、随时间推移的管理变化、患者特征、手术变量和临床结果。根据治疗方法分为保守、内镜、再手术和多模式(联合)治疗四组。结果:内镜治疗于2011年首次引入,并逐渐取代再手术,目前占32.5%。术后平均8.4 d诊断为EJL。总体住院死亡率为6.1%(10/162)。排除保守治疗后,内镜治疗成功率最高(94.3%,p = 0.004)。内镜组和保守组与再手术组和多模式治疗组相比,恢复饮食所需时间和住院时间均显著缩短(p < 0.001)。此外,尽管多模式治疗的患者漏损后住院费用最高(p < 0.001),但保守治疗或内镜干预的患者总住院费用显著降低(p < 0.001)。结论:在过去的二十年中,EJL的治疗已经转向内镜方法。内窥镜治疗产生优越的临床结果,应考虑适当候选人的主要选择。
{"title":"Current status of treatment for esophagojejunostomy leakage after total gastrectomy in patients with gastric cancer: a multicenter retrospective study in Korea.","authors":"Min-Chan Kim, Mi Ran Jung, Jeong Ju Noh, Sunghwa Kang, Jae Hun Chung, Ji-Ho Park, Tae-Han Kim, Jae Kyun Park, Yoonhong Kim, Sang Hyuk Seo, Sung Eun Kim, Oh Kyung Kwon, Ji Yeon Park, Ki Bum Park, Sun-Hwi Hwang, Si-Hak Lee, Young-Joon Lee, Sang-Ho Jeong, Tae-Yong Jeon, Dae Hwan Kim, Chang In Choi, Ki Young Yoon, Kyung Won Seo, Ki Hyun Kim, Sang Hoon Oh, Kwang Hee Kim","doi":"10.7602/jmis.2025.28.4.184","DOIUrl":"10.7602/jmis.2025.28.4.184","url":null,"abstract":"<p><strong>Purpose: </strong>Esophagojejunostomy leakage (EJL) remains one of the most critical complications following total gastrectomy for gastric cancer. This study aimed to evaluate the evolving therapeutic approaches and clinical outcomes of EJL using data from a large-scale multicenter retrospective cohort.</p><p><strong>Methods: </strong>Among 6,577 patients who underwent total gastrectomy or proximal gastrectomy with double tract reconstruction at nine institutions from 2003 to 2024, 196 (3.0%) developed EJL. Of these, 162 patients with comprehensive clinical data were included in the final analysis. The study examined treatment modalities, changes in management over time, patient characteristics, surgical variables, and clinical outcomes. Four groups were defined according to treatment approach: conservative, endoscopic, reoperation, and multimodal (combined) therapy.</p><p><strong>Results: </strong>Endoscopic therapy was first introduced in 2011 and has progressively supplanted reoperation, now comprising 32.5% of cases. The average time to EJL diagnosis was 8.4 days after surgery. Overall in-hospital mortality was 6.1% (10/162). When conservative management was excluded, endoscopic treatment demonstrated the highest rate of therapeutic success (94.3%, <i>p</i> = 0.004). Both the duration until diet resumption and length of hospital stay were notably reduced in the endoscopic and conservative groups compared with reoperation and multimodal therapy (<i>p</i> < 0.001). Moreover, although the highest post-leakage hospitalization costs were observed with multimodal treatment (<i>p</i> < 0.001), overall hospitalization expenses were significantly lower for patients managed conservatively or with endoscopic intervention (<i>p</i> < 0.001).</p><p><strong>Conclusion: </strong>Over the past two decades, management of EJL has shifted toward endoscopic approaches. Endoscopic therapies yield superior clinical outcomes and should be considered a primary option for appropriate candidates.</p>","PeriodicalId":73832,"journal":{"name":"Journal of minimally invasive surgery","volume":"28 4","pages":"184-192"},"PeriodicalIF":0.0,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12715286/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145764715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of aprepitant, dexamethasone, and ondansetron with dexamethasone and ondansetron for prevention of postoperative nausea and vomiting in high-risk patients undergoing laparoscopic surgeries: a randomized controlled trial in India. 阿瑞吡坦、地塞米松和昂丹司琼与地塞米松和昂丹司琼预防高危腹腔镜手术患者术后恶心呕吐的比较:印度的一项随机对照试验。
Pub Date : 2025-12-15 DOI: 10.7602/jmis.2025.28.4.176
Shalini Bala, Tanvi M Meshram, Pradeep Bhatia, Darshana Rathod, Manbir Kaur, Kamlesh Kumari

Purpose: Following laparoscopic surgeries, patients often experience discomfort and dissatisfaction due to postoperative nausea and vomiting (PONV), despite using a multimodal pharmacological approach. The study compared the effects of triple drug prophylaxis with aprepitant-dexamethasone-ondansetron versus dual drug prophylaxis with dexamethasone-ondansetron in high-risk patients undergoing laparoscopic surgeries.

Methods: This randomized controlled trial enrolled 201 female nonsmokers who used opioids postoperatively and underwent elective laparoscopic surgery. Patients were allocated into two groups: dual prophylactic antiemetics and placebo (control group), and triple prophylactic antiemetics with preoperative administration of aprepitant 80 mg (group A). Group A received oral aprepitant 80 mg 2 hours before the surgery, and the control group received a placebo. Patients were assessed at two time points: 2 hours after surgery, either in the postanesthesia care unit or in the ward, and 24 hours after surgery in the ward.

Results: Patients in group A reported a PONV incidence of 10% as compared to 22.7% in the control group (relative risk,0.43; 95% confidence interval [CI], 0.22-0.89; adjusted p = 0.01) at 2 hours in the postoperative period. At 24 hours postoperatively, patients in group A experienced significantly lower incidence of PONV (10%) compared to the control group (29.7%; relative risk, 0.33; 95% CI, 0.17-0.64; p < 0.001). Also, the need for rescue antiemetics was reported to be lower in patients in group A. No adverse effects were reported with any of the drugs used.

Conclusion: The study suggests that prophylaxis with a triple antiemetic regimen consisting of aprepitant-dexamethasone-ondansetron results in a lower incidence of PONV compared with a two-drug regimen using dexamethasone-ondansetron in high-risk patients with three or more risk factors.

目的:腹腔镜手术后,尽管采用了多模式的药物治疗方法,但患者经常因术后恶心和呕吐(PONV)而感到不适和不满。该研究比较了阿瑞吡坦-地塞米松-昂丹西酮三联预防与地塞米松-昂丹西酮双联预防在高危腹腔镜手术患者中的效果。方法:本随机对照试验纳入201名术后使用阿片类药物并接受择期腹腔镜手术的女性非吸烟者。患者被分为两组:双止吐药加安慰剂组(对照组)和三联止吐药加阿瑞吡坦80 mg (A组)。A组患者术前2小时口服阿瑞吡坦80 mg,对照组患者给予安慰剂。患者在两个时间点进行评估:手术后2小时,在麻醉后护理病房或病房,以及手术后24小时在病房。结果:A组患者术后2小时PONV发生率为10%,对照组为22.7%(相对危险度0.43;95%可信区间[CI], 0.22-0.89;调整后p = 0.01)。术后24小时,A组患者PONV发生率(10%)明显低于对照组(29.7%;相对危险度0.33;95% CI, 0.17-0.64; p < 0.001)。此外,据报道,a组患者对抢救止吐药的需求较低,所使用的任何药物均无不良反应。结论:该研究表明,在具有三个或更多危险因素的高危患者中,与使用地塞米松-昂丹西酮两种药物方案相比,使用阿瑞吡坦-地塞米松-昂丹西酮三重止吐方案预防PONV的发生率较低。
{"title":"Comparison of aprepitant, dexamethasone, and ondansetron with dexamethasone and ondansetron for prevention of postoperative nausea and vomiting in high-risk patients undergoing laparoscopic surgeries: a randomized controlled trial in India.","authors":"Shalini Bala, Tanvi M Meshram, Pradeep Bhatia, Darshana Rathod, Manbir Kaur, Kamlesh Kumari","doi":"10.7602/jmis.2025.28.4.176","DOIUrl":"10.7602/jmis.2025.28.4.176","url":null,"abstract":"<p><strong>Purpose: </strong>Following laparoscopic surgeries, patients often experience discomfort and dissatisfaction due to postoperative nausea and vomiting (PONV), despite using a multimodal pharmacological approach. The study compared the effects of triple drug prophylaxis with aprepitant-dexamethasone-ondansetron versus dual drug prophylaxis with dexamethasone-ondansetron in high-risk patients undergoing laparoscopic surgeries.</p><p><strong>Methods: </strong>This randomized controlled trial enrolled 201 female nonsmokers who used opioids postoperatively and underwent elective laparoscopic surgery. Patients were allocated into two groups: dual prophylactic antiemetics and placebo (control group), and triple prophylactic antiemetics with preoperative administration of aprepitant 80 mg (group A). Group A received oral aprepitant 80 mg 2 hours before the surgery, and the control group received a placebo. Patients were assessed at two time points: 2 hours after surgery, either in the postanesthesia care unit or in the ward, and 24 hours after surgery in the ward.</p><p><strong>Results: </strong>Patients in group A reported a PONV incidence of 10% as compared to 22.7% in the control group (relative risk,0.43; 95% confidence interval [CI], 0.22-0.89; adjusted <i>p</i> = 0.01) at 2 hours in the postoperative period. At 24 hours postoperatively, patients in group A experienced significantly lower incidence of PONV (10%) compared to the control group (29.7%; relative risk, 0.33; 95% CI, 0.17-0.64; <i>p</i> < 0.001). Also, the need for rescue antiemetics was reported to be lower in patients in group A. No adverse effects were reported with any of the drugs used.</p><p><strong>Conclusion: </strong>The study suggests that prophylaxis with a triple antiemetic regimen consisting of aprepitant-dexamethasone-ondansetron results in a lower incidence of PONV compared with a two-drug regimen using dexamethasone-ondansetron in high-risk patients with three or more risk factors.</p>","PeriodicalId":73832,"journal":{"name":"Journal of minimally invasive surgery","volume":"28 4","pages":"176-183"},"PeriodicalIF":0.0,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12715281/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145764685","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An unexpected twist in bowel obstruction: a case report. 肠梗阻的意外转折:一例报告。
Pub Date : 2025-12-15 DOI: 10.7602/jmis.2025.28.4.193
Abha Chugh, Manish Gupta, Srikrishna Das, Vijay Arora

Internal hernias are a rare cause of small bowel obstruction. Broad ligament hernias are particularly rare and often present with nonspecific symptoms and subtle imaging findings, complicating diagnosis. Herein, the case of a 34-year-old female with acute colicky pain, obstipation, and intermittent constipation lasting 1 week is reported. Clinical examination revealed tachycardia, abdominal distension, and generalized tenderness. Imaging confirmed small bowel obstruction without an identifiable cause. Emergency laparoscopy revealed a 5-cm defect in the left broad ligament, through which viable bowel had herniated, resulting in a closed-loop obstruction. The herniated bowel was reduced, and the defect was closed with continuous sutures. The patient's recovery was uneventful. This case underscores the diagnostic challenges of broad ligament hernias and highlights the utility of laparoscopy as a diagnostic and therapeutic tool. Despite their rarity, broad ligament hernias should be considered in women with unexplained bowel obstruction.

内疝是一种罕见的小肠梗阻的原因。宽韧带疝特别罕见,通常表现为非特异性症状和细微的影像学表现,使诊断复杂化。在此,病例34岁女性急性绞痛,顽固性便秘和间歇性便秘持续1周的报告。临床检查显示心动过速,腹胀和全身压痛。影像学证实小肠梗阻,原因不明。急诊腹腔镜检查显示左侧阔韧带有一个5cm的缺损,活肠通过该缺损疝出,导致闭环梗阻。将疝出的肠缩小,并用连续缝线缝合缺损。病人的康复平安无事。本病例强调了诊断宽韧带疝的挑战,并强调了腹腔镜作为诊断和治疗工具的实用性。尽管其罕见,宽韧带疝应考虑妇女不明原因的肠梗阻。
{"title":"An unexpected twist in bowel obstruction: a case report.","authors":"Abha Chugh, Manish Gupta, Srikrishna Das, Vijay Arora","doi":"10.7602/jmis.2025.28.4.193","DOIUrl":"10.7602/jmis.2025.28.4.193","url":null,"abstract":"<p><p>Internal hernias are a rare cause of small bowel obstruction. Broad ligament hernias are particularly rare and often present with nonspecific symptoms and subtle imaging findings, complicating diagnosis. Herein, the case of a 34-year-old female with acute colicky pain, obstipation, and intermittent constipation lasting 1 week is reported. Clinical examination revealed tachycardia, abdominal distension, and generalized tenderness. Imaging confirmed small bowel obstruction without an identifiable cause. Emergency laparoscopy revealed a 5-cm defect in the left broad ligament, through which viable bowel had herniated, resulting in a closed-loop obstruction. The herniated bowel was reduced, and the defect was closed with continuous sutures. The patient's recovery was uneventful. This case underscores the diagnostic challenges of broad ligament hernias and highlights the utility of laparoscopy as a diagnostic and therapeutic tool. Despite their rarity, broad ligament hernias should be considered in women with unexplained bowel obstruction.</p>","PeriodicalId":73832,"journal":{"name":"Journal of minimally invasive surgery","volume":"28 4","pages":"193-197"},"PeriodicalIF":0.0,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12715282/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145764679","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pioneering complex biliary surgeries with the Revo-i robotic surgical system: initial cases of choledochal cyst and gallbladder tumor (with video). revi机器人手术系统在复杂胆道手术中的开创性应用:胆总管囊肿和胆囊肿瘤的初始病例(附视频)。
Pub Date : 2025-12-15 DOI: 10.7602/jmis.2025.28.4.198
Jae Seung Kang, Seongryong Kim, Jinhyong Kang, Joune Seup Lee

Robotic surgery systems, including the Korean-developed Revo-i surgical robotic system (Meerecompany Inc.), have expanded from routine cholecystectomies to complex hepatobiliary and pancreatic (HBP) procedures. We report two cases: one of choledochal cyst excision with Roux-en-Y hepaticojejunostomy, and another of extended cholecystectomy for gallbladder cancer, both performed entirely robotically using Revo-i. Both patients recovered without immediate postoperative complications and were discharged on postoperative day 7. These cases are the first to demonstrate the technical feasibility of fully robotic complex HBP surgeries with Revo-i, including the first reported choledochal cyst excision and extended cholecystectomy. Further experience and research are needed to confirm the safety and broader applicability of this system in HBP surgery.

机器人手术系统,包括韩国开发的revi手术机器人系统(meerecompinc .),已经从常规的胆囊切除扩展到复杂的肝胆胰(HBP)手术。我们报告了两个病例:一个是胆总管囊肿切除与Roux-en-Y肝空肠吻合术,另一个是胆囊癌的扩展胆囊切除术,这两个病例都完全使用rego -i机器人进行。两例患者均无术后立即并发症,于术后第7天出院。这些病例首次证明了使用Revo-i进行全机器人复杂HBP手术的技术可行性,包括首次报道的胆总管囊肿切除术和扩展胆囊切除术。需要进一步的经验和研究来证实该系统在HBP手术中的安全性和更广泛的适用性。
{"title":"Pioneering complex biliary surgeries with the Revo-i robotic surgical system: initial cases of choledochal cyst and gallbladder tumor (with video).","authors":"Jae Seung Kang, Seongryong Kim, Jinhyong Kang, Joune Seup Lee","doi":"10.7602/jmis.2025.28.4.198","DOIUrl":"10.7602/jmis.2025.28.4.198","url":null,"abstract":"<p><p>Robotic surgery systems, including the Korean-developed Revo-i surgical robotic system (Meerecompany Inc.), have expanded from routine cholecystectomies to complex hepatobiliary and pancreatic (HBP) procedures. We report two cases: one of choledochal cyst excision with Roux-en-Y hepaticojejunostomy, and another of extended cholecystectomy for gallbladder cancer, both performed entirely robotically using Revo-i. Both patients recovered without immediate postoperative complications and were discharged on postoperative day 7. These cases are the first to demonstrate the technical feasibility of fully robotic complex HBP surgeries with Revo-i, including the first reported choledochal cyst excision and extended cholecystectomy. Further experience and research are needed to confirm the safety and broader applicability of this system in HBP surgery.</p>","PeriodicalId":73832,"journal":{"name":"Journal of minimally invasive surgery","volume":"28 4","pages":"198-204"},"PeriodicalIF":0.0,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12715287/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145764650","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Three are better than two: redefining prophylaxis for postoperative nausea and vomiting. 三个比两个好:重新定义术后恶心和呕吐的预防。
Pub Date : 2025-12-15 DOI: 10.7602/jmis.2025.28.4.167
Hyun Kang
{"title":"Three are better than two: redefining prophylaxis for postoperative nausea and vomiting.","authors":"Hyun Kang","doi":"10.7602/jmis.2025.28.4.167","DOIUrl":"10.7602/jmis.2025.28.4.167","url":null,"abstract":"","PeriodicalId":73832,"journal":{"name":"Journal of minimally invasive surgery","volume":"28 4","pages":"167-168"},"PeriodicalIF":0.0,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12715280/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145764667","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transversus abdominis release in incisional hernia repair: a comprehensive review. 腹横肌松解在切口疝修补中的应用综述。
Pub Date : 2025-12-15 DOI: 10.7602/jmis.2025.28.4.169
Sang Hyun Kim, Tae Kyoung Ha

Incisional hernia remains a significant challenge following abdominal surgery, necessitating robust repair strategies to mitigate recurrence and wound complications. While the introduction of synthetic mesh has improved durability, complex defects with significant loss of domain or lateral extension often exceed the limitations of traditional repair techniques. The transversus abdominis release (TAR) has emerged as a cornerstone technique in abdominal wall reconstruction, offering a physiological solution by mobilizing the posterior rectus sheath and creating a wide retromuscular plane for extensive mesh reinforcement. This review provides a comprehensive overview of the TAR procedure, encompassing anatomical considerations, current classification systems, and specific indications. We detail the surgical technique, emphasizing critical steps such as neurovascular preservation and the recent "Madrid modification" for enhanced outcomes. Furthermore, we compare the established open TAR with the emerging robotic TAR, highlighting the latter's benefits in reducing wound morbidity and hospital stay, as evidenced by recent meta-analyses. The review also addresses long-term outcomes, contrasting patient-reported bulges with clinical recurrence, and underscores the importance of patient-reported outcome measures for evaluating true surgical success. Finally, we discuss the evolving role of TAR in Korea, emphasizing the need for cost-effectiveness studies and structured training programs to establish it as a standard of care. This article aims to provide surgeons with an expert-level update on TAR, facilitating its optimal application in complex hernia repair.

切口疝仍然是腹部手术后的一个重大挑战,需要强有力的修复策略来减少复发和伤口并发症。虽然合成网格的引入提高了耐用性,但具有显著区域损失或横向延伸的复杂缺陷通常超出传统修复技术的限制。腹横松解术(TAR)已成为腹壁重建的基础技术,通过动员后直肌鞘和创造宽的肌后平面来广泛加强网状物,提供了一种生理解决方案。这篇综述提供了TAR手术的全面概述,包括解剖学上的考虑、目前的分类系统和具体的适应症。我们详细介绍了手术技术,强调关键步骤,如神经血管保存和最近的“马德里修改”,以提高结果。此外,我们比较了已建立的开放式TAR和新兴的机器人TAR,强调后者在减少伤口发病率和住院时间方面的好处,最近的荟萃分析证明了这一点。该综述还讨论了长期结果,对比了患者报告的肿块和临床复发,并强调了患者报告的结果指标对评估真正的手术成功的重要性。最后,我们讨论了TAR在韩国不断发展的作用,强调需要进行成本效益研究和有组织的培训计划,以使其成为一种护理标准。本文旨在为外科医生提供专家水平的TAR更新,促进其在复杂疝修补中的最佳应用。
{"title":"Transversus abdominis release in incisional hernia repair: a comprehensive review.","authors":"Sang Hyun Kim, Tae Kyoung Ha","doi":"10.7602/jmis.2025.28.4.169","DOIUrl":"10.7602/jmis.2025.28.4.169","url":null,"abstract":"<p><p>Incisional hernia remains a significant challenge following abdominal surgery, necessitating robust repair strategies to mitigate recurrence and wound complications. While the introduction of synthetic mesh has improved durability, complex defects with significant loss of domain or lateral extension often exceed the limitations of traditional repair techniques. The transversus abdominis release (TAR) has emerged as a cornerstone technique in abdominal wall reconstruction, offering a physiological solution by mobilizing the posterior rectus sheath and creating a wide retromuscular plane for extensive mesh reinforcement. This review provides a comprehensive overview of the TAR procedure, encompassing anatomical considerations, current classification systems, and specific indications. We detail the surgical technique, emphasizing critical steps such as neurovascular preservation and the recent \"Madrid modification\" for enhanced outcomes. Furthermore, we compare the established <i>open</i> TAR with the emerging <i>robotic</i> TAR, highlighting the latter's benefits in reducing wound morbidity and hospital stay, as evidenced by recent meta-analyses. The review also addresses long-term outcomes, contrasting patient-reported bulges with clinical recurrence, and underscores the importance of patient-reported outcome measures for evaluating true surgical success. Finally, we discuss the evolving role of TAR in Korea, emphasizing the need for cost-effectiveness studies and structured training programs to establish it as a standard of care. This article aims to provide surgeons with an expert-level update on TAR, facilitating its optimal application in complex hernia repair.</p>","PeriodicalId":73832,"journal":{"name":"Journal of minimally invasive surgery","volume":"28 4","pages":"169-175"},"PeriodicalIF":0.0,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12715283/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145764637","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Robotic retroperitoneal tumor resection: a video vignette. 机器人腹膜后肿瘤切除术:视频短片。
Pub Date : 2025-12-15 DOI: 10.7602/jmis.2025.28.4.205
Rajesh S Shinde, Monika Pohekar, Murali V

The utility of robotic platform remains relatively unexplored in the context of retroperitoneal tumors. The location and complexity of neurovascular anatomy pose additional challenges for surgical planning. Herein, we present the case of a 56-year-old male with a 9 × 7-cm retroperitoneal tumor located within the right iliopsoas muscle, without intraforaminal extent. The surgery was performed using the da Vinci Xi Surgical System (Intuitive Surgical, Inc.). The patient was placed in the left lateral position. Intraoperative and postoperative recovery was uneventful. A transient sensory deficit was noted in the right lower limb, which gradually resolved completely. The patient was discharged on postoperative day 4. Histopathology report confirmed a schwannoma with negative margins. At 1-year follow-up, the patient is doing well with no evidence of disease recurrence. Robotic resection of retroperitoneal tumors appears to be a feasible and safe approach. Proper planning and execution are essential for the successful completion of the surgery and achieving excellent outcomes.

在腹膜后肿瘤的背景下,机器人平台的应用仍然相对未被探索。神经血管解剖的位置和复杂性对手术计划提出了额外的挑战。在此,我们报告一例56岁男性患者,其腹膜后肿瘤位于右侧髂腰肌内,长9 × 7厘米,无椎间孔内肿大。手术采用达芬奇Xi手术系统(Intuitive Surgical, Inc.)。将患者置于左侧侧卧位。术中及术后恢复顺利。右下肢有一过性感觉缺陷,但逐渐完全消失。患者于术后第4天出院。组织病理学报告证实为神经鞘瘤,边缘呈阴性。在1年的随访中,患者恢复良好,无疾病复发迹象。机器人切除腹膜后肿瘤似乎是一种可行和安全的方法。正确的计划和执行对于手术的顺利完成和获得良好的结果至关重要。
{"title":"Robotic retroperitoneal tumor resection: a video vignette.","authors":"Rajesh S Shinde, Monika Pohekar, Murali V","doi":"10.7602/jmis.2025.28.4.205","DOIUrl":"10.7602/jmis.2025.28.4.205","url":null,"abstract":"<p><p>The utility of robotic platform remains relatively unexplored in the context of retroperitoneal tumors. The location and complexity of neurovascular anatomy pose additional challenges for surgical planning. Herein, we present the case of a 56-year-old male with a 9 × 7-cm retroperitoneal tumor located within the right iliopsoas muscle, without intraforaminal extent. The surgery was performed using the da Vinci Xi Surgical System (Intuitive Surgical, Inc.). The patient was placed in the left lateral position. Intraoperative and postoperative recovery was uneventful. A transient sensory deficit was noted in the right lower limb, which gradually resolved completely. The patient was discharged on postoperative day 4. Histopathology report confirmed a schwannoma with negative margins. At 1-year follow-up, the patient is doing well with no evidence of disease recurrence. Robotic resection of retroperitoneal tumors appears to be a feasible and safe approach. Proper planning and execution are essential for the successful completion of the surgery and achieving excellent outcomes.</p>","PeriodicalId":73832,"journal":{"name":"Journal of minimally invasive surgery","volume":"28 4","pages":"205-208"},"PeriodicalIF":0.0,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12715285/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145764638","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on current management of esophagojejunostomy leakage after total gastrectomy. 全胃切除术后食管空肠造口瘘的处理现状评述。
Pub Date : 2025-12-15 DOI: 10.7602/jmis.2025.28.4.165
Su-Mi Kim, Sang Hyun Kim
{"title":"Comment on current management of esophagojejunostomy leakage after total gastrectomy.","authors":"Su-Mi Kim, Sang Hyun Kim","doi":"10.7602/jmis.2025.28.4.165","DOIUrl":"10.7602/jmis.2025.28.4.165","url":null,"abstract":"","PeriodicalId":73832,"journal":{"name":"Journal of minimally invasive surgery","volume":"28 4","pages":"165-166"},"PeriodicalIF":0.0,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12715279/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145764633","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preventing postoperative nausea and vomiting after laparoscopic cholecystectomy: toward personalization. 预防腹腔镜胆囊切除术后恶心呕吐:走向个体化。
Pub Date : 2025-09-15 DOI: 10.7602/jmis.2025.28.3.115
Naru Kim
{"title":"Preventing postoperative nausea and vomiting after laparoscopic cholecystectomy: toward personalization.","authors":"Naru Kim","doi":"10.7602/jmis.2025.28.3.115","DOIUrl":"10.7602/jmis.2025.28.3.115","url":null,"abstract":"","PeriodicalId":73832,"journal":{"name":"Journal of minimally invasive surgery","volume":"28 3","pages":"115-116"},"PeriodicalIF":0.0,"publicationDate":"2025-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12439047/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145066608","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of minimally invasive surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1